Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
E For L Aim PCLBKK:EFORL 36 FCF Yield % is 18.81 as of Aug. 02, 2026, which is 166% above its 10-year median of 7.06. GuruFocus rates BKK:EFORL with a GF Score™ of 36/100 and a GF Value™ of ฿0.15 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, E For L Aim PCL ranks better than 86.44% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
E For L Aim PCL FCF Yield % Related Terms
E For L Aim PCL FCF Yield % Historical Data
* Premium members only.
The historical data trend for E For L Aim PCL's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:EFORL vs MCK, COR, CAH: FCF Yield % Comparison
For the Medical Distribution subindustry, E For L Aim PCL's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
E For L Aim PCL FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, E For L Aim PCL's FCF Yield % distribution charts can be found below:
* The bar in red indicates where E For L Aim PCL's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
E For L Aim PCL (BKK:EFORL) has a FCF Yield % of 18.81 as of Aug. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on E For L Aim PCL and its competitors. This is 166% above median its historical median of 7.06. According to the industry distribution chart, E For L Aim PCL ranks #16 out of 118 companies in the Medical Distribution industry, placing it in the top 13.6%.
Is E For L Aim PCL's FCF Yield % too high?
E For L Aim PCL's current FCF Yield % of 18.81 is 166% above median its 10-year median of 7.06. The Medical Distribution industry median FCF Yield % is 1.82. E For L Aim PCL's value of 18.81 is 933.5% above this industry median. Based on the distribution chart, E For L Aim PCL ranks #16 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, E For L Aim PCL has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does E For L Aim PCL's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, E For L Aim PCL ranks #16 out of 118 companies for FCF Yield %. This places E For L Aim PCL in the top 14% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.82. E For L Aim PCL's value of 18.81 is 933.5% above this benchmark. While the company's 10-year median is 7.06 vs. the industry median of 1.82, E For L Aim PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 1.82, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. E For L Aim PCL's current FCF Yield % of 18.81 is 933.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on E For L Aim PCL and its competitors. For the Medical Distribution industry, the median FCF Yield % is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. E For L Aim PCL's current FCF Yield % is 18.81, which is 166% above median its own 10-year median of 7.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is E For L Aim PCL stock overvalued right now?
Based on GuruFocus' analysis, E For L Aim PCL (BKK:EFORL) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿0.15, compared to a current price of ฿0.12 — trading 20% below its estimated fair value. The current FCF Yield % is 18.81, which is 166% above median its 10-year median of 7.06 and 933.5% above the Medical Distribution industry median of 1.82. E For L Aim PCL's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For E For L Aim PCL (BKK:EFORL), the current FCF Yield % is 18.81 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is E For L Aim PCL (BKK:EFORL) Overvalued in 2026?
Based on GuruFocus' analysis, E For L Aim PCL stock appears to be undervalued.
The current stock price of ฿0.12 is trading 20% below its estimated GF Value™ of ฿0.15.
GuruFocus considers E For L Aim PCL to be Modestly Undervalued.
Key valuation signals for BKK:EFORL:
FCF Yield %: 18.81 (166% above median its 10-year median of 7.06)
GF Value™: ฿0.15 vs. price of ฿0.12 (20% below fair value)
Industry Position: 933.5% above the Medical Distribution median (#16 of 118)
No single metric tells the full story. See the BKK:EFORL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
E For L Aim PCL is engaged in the distribution of medical devices and equipment. The company and subsidiary have distributor agreements for medical devices and equipment with foreign companies. Its products include Patient Monitor System, Central Monitors System, Defibrillator, Automated External Defibrillator (AED), Electrocardiographs, Electroencephalogram (EEG), PSG System (Sleep Labs), and Accessories and Consumables. The group is principally engaged in one operating segment which is the distribution of medical device and equipment and providing service of medical equipment. Their operations are carried out in Thailand.
36GF Score
Get the complete analysis for BKK:EFORL
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:EFORL has been successfully added to your 
